Pharma Mar S.A. Net Asset Quality Index
Pharma Mar S.A. net asset quality index. Pharma Mar S.A. (PHM) has a Net Asset Quality Index of 63.7% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €395.08 Million minus total liabilities of €143.25 Million yields net assets of €251.83 Million. A higher index indicates a stronger, lower-leverage balance sheet. See Pharma Mar S.A. shareholders equity for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Pharma Mar S.A. (2002–2025)
Net asset quality index of Pharma Mar S.A. from 2002 to 2025. This chart shows how Pharma Mar S.A.'s Net Asset Quality Index has evolved across 24 annual periods from 2002 to 2025. As of December 2025, the index stands at 63.7%, representing net assets of €251.83 Million against total assets of €395.08 Million EUR. Check how strategically is Pharma Mar S.A.'s equity deployed to assess the company's strategic physical and investment asset allocation.
Pharma Mar S.A. Net Asset Quality Index by Year (2002–2025)
Pharma Mar S.A. net asset quality index by year from 2002 to 2025. The table below presents the year-by-year Net Asset Quality Index for Pharma Mar S.A. from 2002 to 2025, covering 24 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Pharma Mar S.A. market capitalisation.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 63.7% | €251.83 Million | €395.08 Million | €143.25 Million | ▲ +4.2 pp |
| 2024 | 59.6% | €208.36 Million | €349.64 Million | €141.28 Million | ▲ +2.8 pp |
| 2023 | 56.8% | €193.44 Million | €340.52 Million | €147.08 Million | ▲ +0.1 pp |
| 2022 | 56.7% | €222.96 Million | €393.26 Million | €170.30 Million | ▲ +8.4 pp |
| 2021 | 48.3% | €177.92 Million | €368.39 Million | €190.47 Million | ▲ +17.2 pp |
| 2020 | 31.1% | €102.72 Million | €330.26 Million | €227.54 Million | ▲ +25.1 pp |
| 2019 | 6.0% | €7.46 Million | €124.70 Million | €117.25 Million | ▼ -5.1 pp |
| 2018 | 11.1% | €17.47 Million | €157.68 Million | €140.20 Million | ▼ -1.2 pp |
| 2017 | 12.2% | €22.98 Million | €187.72 Million | €164.74 Million | ▼ -9.7 pp |
| 2016 | 21.9% | €48.49 Million | €221.14 Million | €172.64 Million | ▼ -12.5 pp |
| 2015 | 34.5% | €73.04 Million | €211.94 Million | €138.90 Million | ▲ +4.6 pp |
| 2014 | 29.8% | €60.07 Million | €201.39 Million | €141.32 Million | ▲ +3.7 pp |
| 2013 | 26.1% | €49.44 Million | €189.37 Million | €139.94 Million | ▲ +6.7 pp |
| 2012 | 19.4% | €38.73 Million | €199.83 Million | €161.10 Million | ▲ +3.5 pp |
| 2011 | 15.8% | €34.50 Million | €217.82 Million | €183.31 Million | ▲ +0.7 pp |
| 2010 | 15.1% | €34.86 Million | €230.82 Million | €195.96 Million | ▼ -4.4 pp |
| 2009 | 19.5% | €41.14 Million | €211.31 Million | €170.18 Million | ▼ -4.3 pp |
| 2008 | 23.8% | €49.34 Million | €207.54 Million | €158.20 Million | ▼ -18.8 pp |
| 2007 | 42.5% | €98.81 Million | €232.33 Million | €133.51 Million | ▼ -5.2 pp |
| 2006 | 47.8% | €107.17 Million | €224.41 Million | €117.23 Million | ▼ -43.7 pp |
| 2005 | 91.4% | €360.04 Million | €393.72 Million | €33.68 Million | ▲ +2.1 pp |
| 2004 | 89.3% | €301.23 Million | €337.34 Million | €36.11 Million | ▲ +38.7 pp |
| 2003 | 50.6% | €139.28 Million | €275.47 Million | €136.20 Million | ▼ -10.9 pp |
| 2002 | 61.5% | €166.90 Million | €271.43 Million | €104.53 Million | — |